Hospital Medicine Overview

Principles

Definition

Hospital medicine is an academic and research field dedicated to the comprehensive study of medical care delivered within the inpatient hospital setting. It investigates the clinical, operational, and systemic aspects of patient management during hospitalization, focusing on improving patient outcomes, enhancing quality and safety, optimizing resource utilization, and analyzing care delivery models specific to acute inpatient environments. Key characteristics include its emphasis on complex, often multi-morbid conditions treated during hospitalization, the analysis of care transitions, and the study of interdisciplinary team dynamics within the hospital structure. Its significance lies in generating evidence-based practices that enhance the efficiency, effectiveness, and safety of medical care for hospitalized patients, thereby improving health outcomes and optimizing resource allocation within acute care institutions.

Ontological type

Care Delivery Models

Care Transitions and Discharge

Quality and Safety Metrics

Key developments

Key Figures

Hospital Epidemiology era

Ronald Melzack [1] was affiliated with the Massachusetts Institute of Technology [3] and the University of Washington [4] during the hospital epidemiology era (1947–1983). His key contribution in this era was advancing pain assessment through The McGill Pain Questionnaire: Major properties and scoring methods [7], a 1975 paper that introduced standardized pain measurement and informed hospital outcome analytics. Harold C. Neu [2] was affiliated with Columbia University [5] and the University of Texas Health Science Center at Dallas [6] during this era. His work, exemplified by Deaths from nosocomial infections: Experience in a university hospital and a community hospital [8], highlighted hospital-acquired infection mortality and underscored the need for surveillance and population-level risk management within hospitals.

Risk Stratification & Safety era

Salim Yusuf [1] is a leading clinician-scientist whose work in hospital risk stratification and safety spanned institutions such as McGill University and Génome Québec Innovation Centre [3] and Harvard University [4] during the Risk Stratification & Safety era. His key contributions in this era include influential trials and analyses that underpin risk stratification, most notably the 2001 paper Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation [7], which demonstrated the added prognostic value of dual antiplatelet therapy and informed safety focused practice in ACS management. Susan Chrolavicius [2] is a senior researcher associated with McMaster University [5] and Université Claude Bernard Lyon 1 [6] during this era. Her key contributions in this era center on collaboration in the same 2001 study [7], which helped broaden understanding of dual antiplatelet therapy in ACS without ST-elevation and reinforced the use of risk-based care pathways.

Sepsis-Centered Protocols era

Mitchell M. Levy [1] anchors sepsis-centered hospital medicine in this era, with stints at Johns Hopkins University [3] and the University of Washington [4] shaping practice from 2010 to 2023. Levy [1] contributed to shaping the definitions and guideline frameworks that underpin early recognition and protocolized management, notably the Sepsis-3 paper [7] and the Surviving Sepsis Campaign guidelines from 2012 [8] and 2016 [9], which redefined how sepsis and septic shock are identified and treated and mobilized standardized bundles across hospitals. Jean‐Louis Vincent [2] is associated with Harvard University [5] and the University of California, San Francisco [6] during this era. Vincent [2] modernized critical care sepsis evidence synthesis and drove multicenter guideline adoption, as reflected in Sepsis-3 [7] and the Surviving Sepsis Campaign guidelines from 2012 [8] and 2016 [9], thereby strengthening protocolized, organ‑focused management of septic patients across hospitals.